Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
5.68
0.16 (2.90%)
At close: Oct 06, 2025, 2:51 PM
Kyverna Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
PE Ratio | -0.79 | -0.47 | -1.08 | -1.53 | -2.92 | -5.01 | -15.65 | -20.91 | -24.7 | -17.37 | -38.06 |
PEG Ratio | 0.14 | -0.03 | -0.12 | -0.08 | 0.07 | -0.04 | -0.47 | -1.05 | 0.82 | -0.15 | n/a |
PS Ratio | n/a | n/a | 79.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.59K |
PB Ratio | 0.72 | 0.37 | 0.61 | 0.70 | 1.01 | 1.48 | -9.84 | -11.57 | 3.58 | 16.58 | -17.48 |
P/FCF Ratio | -4.13 | -1.86 | -4.3 | -7.65 | -13.36 | -20.52 | -68.45 | -113.58 | -114.87 | -67.4 | -146.5 |
P/OCF Ratio | -4.15 | -1.86 | -4.36 | -7.68 | -13.93 | -20.96 | -69.68 | -116.19 | -114.9 | -67.56 | -146.7 |
OCF/S Ratio | n/a | n/a | -18.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -31.27 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | -0.07 | -0.09 | 0.03 | n/a | -0.14 |
Quick Ratio | 5.39 | 7.44 | 8.61 | 10.50 | 14.86 | 17.17 | 3.05 | 4.71 | 17.17 | n/a | 4.45 |
Current Ratio | 5.39 | 7.44 | 8.61 | 10.50 | 14.86 | 17.17 | 3.05 | 4.71 | 17.17 | n/a | 4.45 |
Asset Turnover | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
Interest Coverage | -3.17K | -1.9K | -1.52K | -1.21K | -857.31 | -667.23 | -454.83 | -325.64 | -289.17 | -260.11 | -214.02 |
Return on Equity | -0.23 | -0.2 | -0.14 | -0.11 | -0.09 | -0.07 | 0.16 | 0.14 | -0.04 | -0.24 | 0.11 |
Return on Assets | -0.19 | -0.17 | -0.12 | -0.1 | -0.08 | -0.07 | -0.27 | -0.17 | -0.03 | n/a | -0.13 |
Return on Invested Capital | -0.23 | -0.21 | -0.15 | -0.12 | -0.1 | -0.08 | -0.37 | -0.21 | -0.04 | n/a | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | -0.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.33 |
Net Profit Margin | n/a | n/a | -18.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30.13 |
Pretax Profit Margin | n/a | n/a | -18.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30.13 |
Operating Profit Margin | n/a | n/a | -20.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -31.12 |
FCF Margin | n/a | n/a | -18.57 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -31.31 |
EBITDA Margin | n/a | n/a | -18.23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.66 |